STAT+: Neurocrine Biosciences to buy Soleno Therapeutics in $2.9B deal
Neurocrine Biosciences is buying Soleno Therapeutics for $2.9 billion, picking up an approved medicine for a rare disease that causes insatiable hunger.
AD
allison deangelis
via Stat
Updated 1h ago

Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Tesla is down sharply in 2026. JPMorgan sees the stock falling another 60%
Next
Scientists may finally detect hidden ripples in spacetime - ScienceDaily
Related Articles
The Endangered Proboscis Monkey Is Easily Identifiable By One Physical Trait: Its Supersized Schnoz
Smithsonian Magazine-13h ago-1 sources
ScienceBringing tomorrow’s treatments closer to home
Adventhealth-13h ago-1 sources
ScienceScientists may finally detect hidden ripples in spacetime - ScienceDaily
Google News-13h ago-1 sources